Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2013103
Max Phase: Preclinical
Molecular Formula: C11H13N5O2
Molecular Weight: 247.26
Molecule Type: Small molecule
Associated Items:
ID: ALA2013103
Max Phase: Preclinical
Molecular Formula: C11H13N5O2
Molecular Weight: 247.26
Molecule Type: Small molecule
Associated Items:
Synonyms (1): 6-Deoxycyclopropavir
Synonyms from Alternative Forms(1):
Canonical SMILES: Nc1ncc2ncn(/C=C3/CC3(CO)CO)c2n1
Standard InChI: InChI=1S/C11H13N5O2/c12-10-13-2-8-9(15-10)16(6-14-8)3-7-1-11(7,4-17)5-18/h2-3,6,17-18H,1,4-5H2,(H2,12,13,15)/b7-3-
Standard InChI Key: YJSKWTGXALYVDY-CLTKARDFSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 247.26 | Molecular Weight (Monoisotopic): 247.1069 | AlogP: -0.38 | #Rotatable Bonds: 3 |
Polar Surface Area: 110.08 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 3 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 3.35 | CX LogP: -1.53 | CX LogD: -1.53 |
Aromatic Rings: 2 | Heavy Atoms: 18 | QED Weighted: 0.68 | Np Likeness Score: 0.06 |
1. Li C, Quenelle DC, Prichard MN, Drach JC, Zemlicka J.. (2012) Synthesis and antiviral activity of 6-deoxycyclopropavir, a new prodrug of cyclopropavir., 20 (8): [PMID:22417649] [10.1016/j.bmc.2012.02.031] |
Source(1):